Home
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

601 public trials 70 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Completed

Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation

NCT02226861

Conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML), Bone Marrow Diseases, +24 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Improving Blood Stem Cell Collection and Transplant Procedures

NCT01517035

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, CLL (Chronic Lymphocytic Leukemia), +23 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

NCT01246206

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +34 more
Locations: Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Preparatory Work to Assess Adherence to Oral Chemotherapy

NCT02895542

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations: Wake Forest School of Medicine Winston-Salem, North Carolina, United States

View Trial Details

Completed

Tipifarnib in Treating Patients With Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia, or Undifferentiated Myeloproliferative Disorders

NCT02210858

Conditions: Accelerated Phase of Disease, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Bone Marrow Diseases, +21 more
Locations: Stanford Cancer Institute Palo Alto, California, United States

University of Rochester Rochester, New York, United States

View Trial Details

Completed

Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies

NCT00660920

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +14 more
Locations: ARIAD Investigational Site #075 San Francisco, California, United States

ARIAD Investigational Site #011 Ann Arbor, Michigan, United States

ARIAD Investigational Site #048 Portland, Oregon, United States

ARIAD Investigational Site #076 Nashville, Tennessee, United States

View Trial Details

Completed

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

NCT00539695

Conditions: ALL, AML, Acute Lymphoblastic Leukemia, +31 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details

Completed

Imatinib Mesylate With or Without Interferon Alfa or Cytarabine Compared With Interferon Alfa Followed by Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

NCT00055874

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations: Krankenhaus / Klinikum Krefeld Aachen, Germany

Kreiskrankenhaus Aurich Aurich, Germany

Kreiskrankenhaus Bad Hersfeld, Germany

St. Hedwig Krankenhaus Berlin, Germany

View all 66 locations

View Trial Details

Completed

Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS)

NCT00854646

Conditions: Acute Lymphocytic Leukemia, Acute Myelocytic Leukemia, Bone Marrow Diseases, +24 more
Locations: Mount Sinai Medical Center New York, United States

View Trial Details

Completed

T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

NCT00602693

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +37 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Related conditions